🔎 Trials Near Me

Akèy › Maladi Alzheimer › Florid › The Villages

Etid klinik pou Maladi Alzheimer nan The Villages, FL

15 etid pou Maladi Alzheimer ap chèche patisipan nan sit nan ak bò kote The Villages (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

Ap rekriteFaz 2
  • Charter Research - Lady Lake- Site Number : 8400004, The Villages
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07688213

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Ap rekriteFaz 3
  • Charter Research, The Villages
Laj 55 a 90 · Tout sèks · Mizajou Sep 22, 2026 · NCT06585787

Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Ap rekriteFaz 3
  • Charter Research - Lady Lake/The Villages, The Villages
  • K2 Medical Research - The Villages, Lady Lake · 3 mi lwen
Laj 50 a 90 · Tout sèks · Mizajou Sep 21, 2026 · NCT07177352

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

Ap rekriteFaz 1/2
  • K2 Medical Research - The Villages /ID# 278290, Lady Lake · 3 mi lwen
Laj 50 a 90 · Tout sèks · Mizajou Sep 18, 2026 · NCT07599670

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

Ap rekriteFaz 3
  • Local Institution - 0129, The Villages
  • K2 MEDICAL Research THE VILLAGES, Lady Lake · 3 mi lwen
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Ap rekriteFaz 2
  • Charter Research - Lady Lake, The Villages
Laj 55 a 90 · Tout sèks · Mizajou Sep 1, 2026 · NCT06808984

A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

Ap rekriteFaz 2
  • Charter Research - Lady Lake ( Site 1019), The Villages
Laj 50 a 85 · Tout sèks · Mizajou Aug 26, 2026 · NCT07033494

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Ap rekriteFaz 1
  • Charter Research, LLC, The Villages
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

Ap rekriteFaz 3
  • Charter Research - Lady Lake, The Villages
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216

A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

Ap rekriteFaz 1/2
  • Charter Research, LLC, The Villages
  • K2 Medical Research The Villages LLC, Lady Lake · 3 mi lwen
Laj 35 a 85 · Tout sèks · Mizajou Jul 10, 2026 · NCT05462106

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

Ap rekriteFaz 3
  • Charter Research - The Villages, The Villages
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

Ap rekriteFaz 2
  • Charter Research The Villages, The Villages
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD)

Ap rekriteFaz 1Volontè an sante akeyi
  • K2 Medical Research - The Villages, Lady Lake · 3 mi lwen
Laj 45 a 85 · Tout sèks · Mizajou Jun 4, 2026 · NCT06657768

[18F]PI-2620 Phase 3 Histopathological Study

Ap rekriteFaz 3
  • K2 Medical Research, Lady Lake · 3 mi lwen
Laj 50 ak plis · Tout sèks · Mizajou May 22, 2026 · NCT05641688

Etid Maladi Alzheimer nan lòt vil

Lòt etid nan The Villages

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.